Yamo Pharmaceuticals

0 followers


Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.

Industries

Headquarters

Stage

Employees

Links

Org chart

Chuck Bramlage
Chief Executive Officer

Chuck Bramlage

Collapse
Eugene Prahin
Chief Financial Officer
Tracy Fischer
Senior Vice President – Regulatory Affairs & Quality
Uyen Nguyen
Vice President Of Clinical Research Operations